China Labs, DEI Mandates, and Gain of Function | Dr. Jay Bhattacharya
What this video covers
In this American Thought Leaders interview, host Jan Jekielek presses Dr. Jay Bhattacharya — by then nearly a year into his tenure as NIH director — on how the world’s largest public funder of biomedical research is changing under his leadership. The interview is structured as an accountability check: a list of specific, pointed questions about what has actually been stopped, cut, or restructured.
Bhattacharya’s stated top priority is ending what he calls “funding the scientific enterprise for the sake of funding science.” He argues the NIH’s $50 billion annual budget, spread across 27 institutes and some 20,000 employees, had become an end in itself — producing papers rather than better health outcomes. The goal he articulates is a reorientation toward measurable improvements in American health and longevity.
The conversation moves through the most politically charged items on his agenda: whether NIH has fully stopped funding gain-of-function research, whether it continues to fund research with China, how international grants have been restructured, whether DEI-related grants have been eliminated, what is being done to reverse the politicization of science, how the agency is addressing reported injuries from mandated mRNA shots, the replication crisis, autism research, and the overhaul of funding allocation. He closes by calling for what he terms a “second scientific revolution” that the NIH has the capacity to induce.
Key points
- Bhattacharya argues the NIH’s fundamental problem is that it funds science for science’s sake, and says his reforms aim to tie funding to real improvements in health and longevity.
- He addresses whether gain-of-function research funding has been completely halted, presenting the restrictions as a biosecurity necessity. He draws a key distinction: gain of function is not inherently bad — he gives the example of engineering bacteria to produce insulin — but “dangerous gain of function,” which risks catastrophic harm, should never be done. His analogy for regulation is nuclear weapons versus nuclear power.
- He says NIH-funded research collaboration with China “may indeed have led to the pandemic,” and discusses restructuring international grants to prevent dangerous work under poor biosafety protocols.
- He addresses the elimination of grants tied to diversity, equity, and inclusion initiatives, framing it as part of depoliticizing science funding.
- He says the NIH is working to help people who report injuries from mandated mRNA shots, and to investigate the causes of autism — areas he argues were neglected by prior leadership.
- He calls the replication crisis one of science’s central failures and argues NIH must restructure incentives so verification is rewarded.
- He describes his ambition as nothing less than a “second scientific revolution,” arguing the NIH has the scale and capacity to drive it.